Evidence map›Paper›PMID 32999830›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Stiffness of HIV-1 Mimicking Polymer Nanoparticles Modulates Ganglioside-Mediated Cellular Uptake and Trafficking.

Behnaz Eshaghi, Nourin Alsharif, Xingda An, Hisashi Akiyama, Keith A Brown, Suryaram Gummuluru, Björn M Reinhard

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Exploring CD169Vaccines · 2025
    Review
  6. Perfluorocarbon-Loaded Poly(lactide-ACS applied polymer materials · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Virus-Mimicking Polymer Nanoparticles Targeting CD169ACS applied materials & interfaces · 2022
    Article
  17. Targeting of sialoadhesin-expressing macrophages through antibody-conjugated (polyethylene glycol) poly(lactic-co-glycolic acid) nanoparticles.Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology · 2022
    Article
  18. Tuning the Elasticity of Polymersomes for Brain Tumor Targeting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Behnaz EshaghiDepartment of Chemistry and The Photonics Center Boston University Boston MA 02215 USA.
Nourin AlsharifDepartment of Mechanical Engineering and The Photonics Center Boston University Boston MA 02215 USA.
Xingda AnDepartment of Chemistry and The Photonics Center Boston University Boston MA 02215 USA.
Hisashi AkiyamaDepartment of Microbiology Boston University School of Medicine Boston MA 02118 USA.
Keith A BrownDepartment of Mechanical Engineering and The Photonics Center Boston University Boston MA 02215 USA.
Suryaram GummuluruDepartment of Microbiology Boston University School of Medicine Boston MA 02118 USA.ORCID https://orcid.org/0000-0002-8606-8481
Björn M ReinhardDepartment of Chemistry and The Photonics Center Boston University Boston MA 02215 USA.ORCID https://orcid.org/0000-0003-2550-5331
Boston University · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Mechanism of cell-associated HIV-1 transmissionR01AI064099 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 2005 to 2020
$5.9M
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon CouplingR01CA138509 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Bjoern Markus Reinhard · 2009 to 2026
$5.9M
GM3 Nanoparticles for Sustained Delivery of Anti-Retrovirals to Lymphatic TissuesR01AI132111 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM, REINHARD, BJOERN MARKUS · 2018 to 2022
$2.7M
NCI NIH HHS R01 CA138509NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI064099NIAID NIH HHS R01 AI132111
6 · The paper itself

Abstract

The monosialodihexosylganglioside, GM3, and its binding to CD169 (Siglec-1) have been indicated as key factors in the glycoprotein-independent sequestration of the human immunodeficiency virus-1 (HIV-1) in virus-containing compartments (VCCs) in myeloid cells. Here, lipid-wrapped polymer nanoparticles (NPs) are applied as a virus-mimicking model to characterize the effect of core stiffness on NP uptake and intracellular fate triggered by GM3-CD169 binding in macrophages. GM3-functionalized lipid-wrapped NPs are assembled with poly(lactic-

Indexed as

biomimetic nanoparticlesendocytosislectinslipid‐wrapped nanoparticlessiglec‐1

Identifiers

PMID32999830
PMCPMC7509657
OpenAlexW3045819362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.